AVTX - Avalo Therapeutics, Inc.
IEX Last Trade
8.2
0 0%
Share volume: 700
Last Updated: Fri 27 Dec 2024 08:01:43 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$8.20
0.00
0.00%
Summary score
31%
Profitability
35%
Dept financing
24%
Liquidity
27%
Performance
30%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-23.18%
Return on assets
-22.87%
Return on sales
-1908.26%
Return on invested capital
-267.29%
Total debt ratio
83.61%
Debt ratio change over timeo
-1.21%
Current Ratio
1.85%
Quick Ratio
1.85%
Cash Position Ratio
1.59%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
22.54%
Return on assets
-16.1%
Return on sales
-1119.73%
Return on invested capital
12.71%
Total debt ratio
106.36%
Debt ratio change over timeo
-2.32%
Current Ratio
1.19%
Quick Ratio
1.19%
Cash Position Ratio
1.02%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
119.99%
Return on assets
-4.23%
Return on sales
0%
Return on invested capital
59.69%
Total debt ratio
181.7%
Debt ratio change over time
-2.78%
Current Ratio
0.52%
Quick Ratio
0.52%
Cash Position Ratio
0.51%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-123.9%
Return on assets
-96.72%
Return on sales
186.96%
Return on invested capital
-28.15%
Total debt ratio
-120.86%
Debt ratio change over time
-1.21%
Current Ratio
-1.31%
Quick Ratio
-1.31%
Cash Position Ratio
-1.24%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AVTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -23.18% | 13.79% | 34.47% | 7.43% |
| Return on assets | -22.87% | 2.76% | 3.15% | 5.62% |
| Return on sales | -1908.26% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -267.29% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 83.61% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.21% | 308.97% | -6.99% | 1.18% |
| Dept financing | 23% | 50% | 25% | 7% |
| Current Ratio | 1.19% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 1.19% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 1.02% | 0.36% | 1.28% | 2.93% |
| Liquididy | 42% | 14% | 33% | 75% |
| Short-term ratios | AVTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 22.54% | 13.77% | 13.25% | 3.8% |
| Return on assets | -16.1% | 2.43% | 1.89% | 3.09% |
| Return on sales | -1119.73% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 12.71% | 2.14% | 3.39% | 9.18% |
| Profitability | 50% | 59% | 56% | 72% |
| Total debt ratio | 106.36% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -2.32% | 46.38% | -72.08% | 1.51% |
| Dept financing | 25% | 47% | 22% | 6% |
| Current Ratio | 1.19% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 1.19% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 1.02% | 0.36% | 1.28% | 2.93% |
| Liquididy | 21% | 12% | 31% | 75% |